These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 37713762)
1. A synthetic delivery vector for mucosal vaccination. Billet A; Hadjerci J; Tran T; Kessler P; Ulmer J; Mourier G; Ghazarian M; Gonzalez A; Thai R; Urquia P; Van Baelen AC; Meola A; Fernandez I; Deville-Foillard S; MacDonald E; Paolini L; Schmidt F; Rey FA; Kay MS; Tartour E; Servent D; Johannes L Biomaterials; 2023 Nov; 302():122298. PubMed ID: 37713762 [TBL] [Abstract][Full Text] [Related]
2. Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2. Jung HE; Ku KB; Kang BH; Park JH; Kim HC; Kim KD; Lee HK Antiviral Res; 2023 Aug; 216():105656. PubMed ID: 37327877 [TBL] [Abstract][Full Text] [Related]
3. STxB as an Antigen Delivery Tool for Mucosal Vaccination. Tartour E; Johannes L Toxins (Basel); 2022 Mar; 14(3):. PubMed ID: 35324699 [TBL] [Abstract][Full Text] [Related]
4. An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa. Vesin B; Lopez J; Noirat A; Authié P; Fert I; Le Chevalier F; Moncoq F; Nemirov K; Blanc C; Planchais C; Mouquet H; Guinet F; Hardy D; Vives FL; Gerke C; Anna F; Bourgine M; Majlessi L; Charneau P Mol Ther; 2022 Sep; 30(9):2984-2997. PubMed ID: 35484842 [TBL] [Abstract][Full Text] [Related]
5. CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus. Lee W; Kingstad-Bakke B; Kedl RM; Kawaoka Y; Suresh M J Virol; 2021 Jul; 95(15):e0053021. PubMed ID: 33952647 [TBL] [Abstract][Full Text] [Related]
6. Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2. Stewart EL; Counoupas C; Johansen MD; Nguyen DH; Miemczyk S; Hansbro NG; Ferrell KC; Ashhurst A; Alca S; Ashley C; Steain M; Britton WJ; Hansbro PM; Petrovsky N; Triccas JA Mucosal Immunol; 2022 Jun; 15(6):1405-1415. PubMed ID: 36411332 [TBL] [Abstract][Full Text] [Related]
7. ChAdOx1-S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination. Cokarić Brdovčak M; Materljan J; Šustić M; Ravlić S; Ružić T; Lisnić B; Miklić K; Brizić I; Pribanić Matešić M; Juranić Lisnić V; Halassy B; Rončević D; Knežević Z; Štefan L; Bertoglio F; Schubert M; Čičin-Šain L; Markotić A; Jonjić S; Krmpotić A Eur J Immunol; 2022 Jun; 52(6):936-945. PubMed ID: 35304741 [TBL] [Abstract][Full Text] [Related]
13. Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge. Tan X; Sande JL; Pufnock JS; Blattman JN; Greenberg PD J Virol; 2011 Aug; 85(16):8316-27. PubMed ID: 21653670 [TBL] [Abstract][Full Text] [Related]
14. Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants. Kingstad-Bakke B; Lee W; Chandrasekar SS; Gasper DJ; Salas-Quinchucua C; Cleven T; Sullivan JA; Talaat A; Osorio JE; Suresh M Proc Natl Acad Sci U S A; 2022 May; 119(20):e2118312119. PubMed ID: 35561224 [TBL] [Abstract][Full Text] [Related]
15. Mucosal Priming with a Recombinant Influenza A Virus-Vectored Vaccine Elicits T-Cell and Antibody Responses to HIV-1 in Mice. Wang J; Shu T; Deng W; Zheng Y; Liao M; Ye X; Han L; He P; Zheng X; Li T; Feng Y; Hu F; Li P; Sun C; Chen L; Li F; Feng L J Virol; 2021 May; 95(12):. PubMed ID: 33789991 [TBL] [Abstract][Full Text] [Related]
16. Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8 Ishii H; Nomura T; Yamamoto H; Nishizawa M; Thu Hau TT; Harada S; Seki S; Nakamura-Hoshi M; Okazaki M; Daigen S; Kawana-Tachikawa A; Nagata N; Iwata-Yoshikawa N; Shiwa N; Suzuki T; Park ES; Ken M; Onodera T; Takahashi Y; Kusano K; Shimazaki R; Suzaki Y; Ami Y; Matano T Cell Rep Med; 2022 Feb; 3(2):100520. PubMed ID: 35233545 [TBL] [Abstract][Full Text] [Related]
17. Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines. Mouro V; Fischer A Mucosal Immunol; 2022 Apr; 15(4):584-594. PubMed ID: 35505121 [TBL] [Abstract][Full Text] [Related]
18. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Afkhami S; D'Agostino MR; Zhang A; Stacey HD; Marzok A; Kang A; Singh R; Bavananthasivam J; Ye G; Luo X; Wang F; Ang JC; Zganiacz A; Sankar U; Kazhdan N; Koenig JFE; Phelps A; Gameiro SF; Tang S; Jordana M; Wan Y; Mossman KL; Jeyanathan M; Gillgrass A; Medina MFC; Smaill F; Lichty BD; Miller MS; Xing Z Cell; 2022 Mar; 185(5):896-915.e19. PubMed ID: 35180381 [TBL] [Abstract][Full Text] [Related]